Autoimmune Thyroiditis
17
0
0
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (17)
Dysregulation of the Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis: A Case-Control Study
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism
The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis
Effects of Low-Level Laser Therapy on Oxidative Stress Levels
Gluten-free Diet in Women With Autoimmune Thyroiditis
Selenium Supplementation in Autoimmune Thyroiditis
Thyroid Hormone Values and Anti-thyroid Peroxidase Antibody Positivity in Recurrent Pregnancy Loss
Identity Oriented Psychotrauma Therapy on Hashimoto in Adults
Selenium Supplementation in Youths With Autoimmune Thyroiditis
Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Thyroid in Bariatric Surgery
Selenium Supplementation in Pregnancy
Low Level Laser Therapy for Autoimmune Thyroiditis
Oxidative Status in Children With Autoimmune Thyroiditis
Low-Level Laser Therapy in Chronic Autoimmune Thyroiditis
Selenium Treatment in Autoimmune Thyroiditis (AIT)